Status:
RECRUITING
Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
ModernaTX, Inc.
Conditions:
Cytomegalovirus Infections
Eligibility:
All Genders
1-36 years
Brief Summary
The goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularl...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Children
- All children up to and including 36 months at time of signed consent regardless of duration of attendance at the center. Children living in the same household can each be enrolled.
- Parent(s) has provided written informed consent for the child to be screened for CMV by saliva PCR collected at the center or at home
- Center Staff
- Individuals who regularly (average \>/= 5 weeks per year) work inside the center in any role, including employed, contracted, volunteer, and full or part time.
- Staff member has provided written informed consent to be screened for CMV by saliva PCR collected at the center or at home
- Exclusion Criteria
- Children
- \>/= 37 months of age
- State Department of Children and Families (DCF) custody
- Center Staff
- Do not regularly (average \< 5 days per year) work inside the center
- Work associated with but not regularly inside the center (e.g. bus drivers or food delivery staff)
Exclusion
Key Trial Info
Start Date :
August 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06522880
Start Date
August 10 2023
End Date
December 31 2027
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMass Chan Medical School
Worcester, Massachusetts, United States, 01655